Skip to main content

Table 3 Changes in KINDL-R parent-rated scale from baseline to endpoint (last observation carried forward)

From: Quality of life in children and adolescents with bipolar I depression treated with olanzapine/fluoxetine combination

KINDL-R domains

OFC

Placebo

Between-group p valuea

N

Mean baseline (SD)

LS mean change (SE)

N

Mean baseline (SD)

LS mean change (SE)

Total

83

46.7 (12.4)

16.0 (1.9)

39

47.1 (11.5)

10.9 (2.6)

0.066

Physical well-being

146

52.8 (20.0)

13.8 (2.3)

72

55.5 (22.0)

11.7 (2.9)

0.475

Emotional well-being

140

49.2 (20.1)

22.6 (2.3)

71

47.1 (16.7)

15.8 (2.9)

0.020

Self-esteem

144

33.3 (22.1)

20.3 (2.4)

69

29.9 (20.5)

13.6 (3.0)

0.030

Family

146

48.0 (20.5)

18.4 (2.1)

71

55.0 (19.5)

11.0 (2.7)

0.006

Friends

139

51.1 (19.9)

18.2 (2.3)

62

53.9 (20.4)

13.7 (3.0)

0.137

School

94

45.7 (15.0)

9.0 (2.0)

43

49.9 (14.6)

3.7 (2.7)

0.057

Disease

8

53.1 (25.1)

11.0 (7.4)

6

47.2 (30.2)

5.3 (7.9)

0.603

  1. KINDL-R KINDL questionnaire for measuring health-related quality of life in children and adolescents, LS least squares, N number of patients, OFC olanzapine/fluoxetine combination, SD standard deviation, SE standard error
  2. aDifference between LS mean change scores